Kapoor, Mahima http://orcid.org/0000-0001-5498-3426
Keh, Ryan
Compton, Laura
Morrow, Sarah
Gosal, David
Manji, Hadi
Reilly, Mary M.
Lunn, Michael P.
Lavin, Tim M.
Carr, Aisling S.
Funding for this research was provided by:
Bequest
Medical Research Council
National Institutes of Neurological Diseases and Stroke and office of Rare Diseases
UCLH Biomedical Research Centre
Article History
Received: 12 July 2020
Revised: 28 September 2020
Accepted: 15 November 2020
First Online: 20 February 2021
Compliance with ethical standards
:
: Dr. Lunn was a Primary Investigator in studies for CSL Behring, UCB Pharma, Novartis, and Octapharma. He has also received ad hoc consulting fees from CSL Behring, UCB and an honorarium from Terumo BCT. Dr. Carr reports Grifols sponsorship for attendance at meeting and honorarium from CSL and Lupin for an advisory role. Dr Lavin reports sponsorship from CSL Behring and honorarium from CSL Behring and Grifols. Dr Kapoor reports Grifols sponsorship for attendance at meeting. The remaining authors have no conflicts of interest.
: We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.